BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ashour NA, Abo Elmaaty A, Sarhan AA, Elkaeed EB, Moussa AM, Erfan IA, Al-Karmalawy AA. A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval. Drug Des Devel Ther 2022;16:685-715. [PMID: 35321497 DOI: 10.2147/DDDT.S354841] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Albuquerque PC, Zicker F, Fonseca BP. Advancing drug repurposing research: Trends, collaborative networks, innovation and knowledge leaders. Drug Discovery Today 2022;27:103396. [DOI: 10.1016/j.drudis.2022.103396] [Reference Citation Analysis]
2 Elagawany M, Elmaaty AA, Mostafa A, Abo Shama NM, Santali EY, Elgendy B, Al-Karmalawy AA. Ligand-based design, synthesis, computational insights, and in vitro studies of novel N-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease. J Enzyme Inhib Med Chem 2022;37:2112-32. [PMID: 35912578 DOI: 10.1080/14756366.2022.2105322] [Reference Citation Analysis]
3 Antar SA, Saleh MA, Al-Karmalawy AA. Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2. Life Sci 2022;309:121048. [PMID: 36209833 DOI: 10.1016/j.lfs.2022.121048] [Reference Citation Analysis]
4 Abd-alla HI, Kutkat O, Sweelam HM, Eldehna WM, Mostafa MA, Ibrahim MT, Moatasim Y, Gaballah M, Al-karmalawy AA. Investigating the Potential Anti-SARS-CoV-2 and Anti-MERS-CoV Activities of Yellow Necklacepod among Three Selected Medicinal Plants: Extraction, Isolation, Identification, In Vitro, Modes of Action, and Molecular Docking Studies. Metabolites 2022;12:1109. [DOI: 10.3390/metabo12111109] [Reference Citation Analysis]
5 Cao J, Yang X, Xiong L, Wu M, Chen S, Xiong C, He P, Zong Y, Zhang L, Fu H, Qi Y, Ying X, Liu D, Hu X, Zhang X. Mechanism of N-0385 blocking SARS-CoV-2 to treat COVID-19 based on molecular docking and molecular dynamics. Front Microbiol 2022;13:1013911. [DOI: 10.3389/fmicb.2022.1013911] [Reference Citation Analysis]
6 Zalewska M, Fus W, Konka A, Wystyrk K, Bochenek A, Botor H, Fronczek M, Zembala-John J, Adamek B. An Immune Response to Heterologous ChAdOx1/BNT162b2 Vaccination against COVID-19: Evaluation of the anti-RBD Specific IgG Antibodies Titers and Interferon Gamma Release Assay (IGRA) Test Results. Vaccines (Basel) 2022;10:1546. [PMID: 36146624 DOI: 10.3390/vaccines10091546] [Reference Citation Analysis]
7 Sahoo R, Sahu P, Swargam S, Kumari I, Behera B. Repurposing small molecules of Tephrosia purpurea against SARS-CoV-2 main protease. J Biomol Struct Dyn 2022;:1-12. [PMID: 35983619 DOI: 10.1080/07391102.2022.2112616] [Reference Citation Analysis]